Invention Grant
- Patent Title: Anc80 encoding sphingolipid-metabolizing proteins for mitigating disease-induced tissue damage
-
Application No.: US16567771Application Date: 2019-09-11
-
Publication No.: US11618893B2Publication Date: 2023-04-04
- Inventor: Efrat Eliyahu , Adam Vincek , Anthony Fargnoli , Michael Katz
- Applicant: Icahn School of Medicine at Mount Sinai
- Applicant Address: US NY New York
- Assignee: Icahn School of Medicine at Mount Sinai
- Current Assignee: Icahn School of Medicine at Mount Sinai
- Current Assignee Address: US NY New York
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Main IPC: C12N9/80
- IPC: C12N9/80 ; C12N15/86 ; C12N15/52 ; A61K48/00
Abstract:
The present disclosure relates generally to the use of sphingolipid-metabolizing proteins to mitigate or minimize tissue damage resulting from injury or from disease, for example, pulmonary arterial hypertension (PAH) when the sphingolipid-metabolizing protein is delivered via expression from an Anc80 vector.
Public/Granted literature
- US20200002696A1 ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS FOR MITIGATING DISEASE-INDUCED TISSUE DAMAGE Public/Granted day:2020-01-02
Information query
IPC分类:
